Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Kirsti Bjerkan"'
1
Frequency of cholelithiasis in need of surgical or endoscopic treatment a decade or more after Roux-en-Y gastric bypass
Autor: Ingrid Belgau, Gjermund Johnsen, Hallvard Græslie, Ronald Mårvik, Siren Nymo, Kirsti Bjerkan, Åsne Hyldmo, Christian Klöckner, Bård Kulseng, Dag Hoff, Jorunn Sandvik
Publikováno v: Surgical Endoscopy. 37:1349-1356
Background Symptomatic cholelithiasis requiring treatment is a known side effect after Roux-en-Y gastric bypass (RYGB), but reported rates vary greatly. The objectives for this study were to evaluate the long-term frequency of surgical or endoscopic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::214918fc38fb0c75e73a66f1c5a6b4f0
https://doi.org/10.1007/s00464-022-09676-y
Zobrazit plný text záznamu
2
Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
Autor: Liv Elin Torheim, Lisa Garnweidner-Holme, Mirjam Lukasse, Kirsti Bjerkan, Josef Noll, Anne Marie Lilleengen, Annhild Mosdøl, Laura Terragni, Anne Flem Jacobsen, Seraj Fayyad, Pål Joranger, Iren Borgen, Milada Cvancarova Småstuen
Publikováno v: BMJ Open
Introduction The promotion of a healthy diet, physical activity and measurement of blood glucose levels are essential components in the care for women with gestational diabetes mellitus (GDM). Smartphones offer a new way to promote health behaviour.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1170222670d98a9dcaf0f99b6590bae4
https://hdl.handle.net/10642/5084
Zobrazit plný text záznamu
3
Great Health Benefits But No Change in Employment or Psychopharmaceutical Drug Use 2 Years After Roux-en-Y Gastric Bypass
Autor: Eva Rustad de Brisis, Kirsti Bjerkan, Anne-Marie Aas, E B Løken, Susanna E Hanvold, Sofie F. Paus, Helga Refsum
Publikováno v: Obesity surgery. 25(9)
The aim was to examine health benefits and lifestyle factors after Roux-en-Y gastric bypass (RYGB). Patients (n = 165) were investigated 2 years after RYGB in relation to psychopharmaceutical drugs, employment status, type 2 diabetes mellitus (T2DM),
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f88d7150bd15505aa5071c71a994355
https://pubmed.ncbi.nlm.nih.gov/25638656
Zobrazit plný text záznamu
4
Fluvastatin and lifestyle modification for reduction of carotid intima–media thickness and left ventricular mass progression in drug-treated hypertensives
Autor: Ingvar Hjermann, Sigmund A. Anderssen, Anne Hjelstuen, Ingar Holme, Kirsti Bjerkan
Publikováno v: Atherosclerosis. 178:387-397
The Hypertension High Risk Management trial (HYRIM) investigated the effect of fluvastatin treatment and lifestyle intervention on development of carotid intima-media thickness (IMT) in drug-treated hypertensive patients.HYRIM was a placebo-controlle
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8937ae84464cfe2b5df70916b6af7ffe
https://doi.org/10.1016/j.atherosclerosis.2004.08.033
Zobrazit plný text záznamu
5
Do Norwegians with diabetes have a healthier diet than the general population?
Autor: Kirsti Bjerkan, Lars Johansson, Nina Lorentsen, Anne-Marie Aas, Ingrid Løvold Mostad
Publikováno v: Norsk Epidemiologi, Vol 23, Iss 1 (2013)
Norsk Epidemiologi
Objective: Review current knowledge about dietary habits among people with diabetes in Norway compared with the general population and nutrient- and food-based dietary recommendations. Method: Baseline dietary data from four intervention studies in s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f18e868344f53e5bcabe8259560facf
http://hdl.handle.net/11250/2624184
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje